Healthcare Archives - Feedback

Healthcare

State-owned NBCC will construct an ayurveda and naturopathy hospital in Goa at a cost of Rs 267.81 crore. NBCC will complete the 50-acre project in the next 24 months. The All India Institute of Ayurveda, Yoga and Naturopathy will also cater to over 500 students every year offering undergraduate, post-graduate and PhD degrees. https://www.business-standard.com/article/pti-stories/nbcc-to-construct-hospital-in-goa-for-rs-268-cr-119020200525_1.html

The government has allocated Rs 6,400 crore towards the implementation of Pradhan Mantri Jan Arogya Yojana (PMJAY) in the upcoming financial year. This increases the centre’s budget to implement the scheme, known popularly as ‘Ayushman Bharat’, by Rs4,000 crore from the previous financial year. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/budget-2019-government-increases-allocation-for-ayushman-bharat-to-rs-6400-crore/articleshow/67790705.cms

Online pharmacy company Medlife International has acquired Medlabz, a digital healthcare platform and ‘diagnostics at home’ provider. It has earmarked Rs. 250 crore to make further acquisitions. While Medlife did not disclose the acquisition sum, that the acquisition will help the company make a stronger push into the diagnostics segment. https://www.thehindubusinessline.com/todays-paper/tp-others/tp-variety/article26144940.ece

Purushottam Agrawal, the founder of specialty pharmaceutical company Ajanta Pharma, has invested $2.4 million in blockchain technology start-up InfiniChains, in his personal capacity. The firm which has offices in Pune and Silicon Valley, US, uses blockchain technology for counterfeit prevention, traceability and authentication of origin of materials in various industries such as fashion and food. […]

Drug firm Strides Pharma Science has decided to exit its investment in Arrow Pharmaceuticals for AUD 394 million (over Rs 2,000 crore). The company’s step-down subsidiary Strides Pharma Global Pte Ltd has approved the sale of its entire Australian business to the Arrow-Apotex merged entity, Strides Pharma Science. https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-to-exit-investment-in-arrow-for-aud-394-million/articleshow/67749695.cms

India Life Sciences Fund, a healthcare and pharmaceuticals-focused private equity fund advised by InvAscent, has raised $250 million for its third growth capital fund, in what could be termed as a sign of increased investor appetite towards sector-specific Indian investment vehicles with credible track record. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/invascent-led-india-life-sciences-fund-raises-250-million/articleshow/67765969.cms

The government is likely to pump more money into primary healthcare and announce over 5,000 more health centres across the country in the coming interim budget, taking cue from its successful rollout of the health insurance scheme under Ayushman Bharat. https://timesofindia.indiatimes.com/india/interim-health-budget-likely-to-rise-by-5-5000-centres-to-come-up/articleshow/67706002.cms

Rajasthan-based RUJ Group has announced its foray into the hospital space. Announcing plans for a 150-bed multi-super-specialty hospital in Jaipur. RUJ Hospitals Pvt Ltd would invest Rs. 150- 200 crore over the next two years for the hospital. The hospital, which will be ready in two years, will provide specialty healthcare services, including critical care, CTVS, […]

Healthians, a diagnostics start-up is planning expansion into southern India with a planned outlay of Rs. 50 crore. The start-up, which began operations in 2015 and backed by cricketer Yuvraj Singh’s investment venture YouWeCan and Asuka Holdings amongst others, has launched its first pathology lab in Bengaluru, as part of the expansion plan. https://www.thehindubusinessline.com/todays-paper/tp-others/tp-states/article25997604.ece

Indoco Remedies is in initial discussions with investors such as Zydus Cadila and Lupin, along with private equity funds including TPG Capital Management and Temasek Holdings to sell part of its domestic business in a deal valued at Rs 500-600 crore. https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/indoco-in-talks-to-sell-part-of-india-operations/articleshow/67549954.cms